Thousands more patients to access second ground-breaking antiviral
Thousands more vulnerable people are eligible to receive the UK’s second antiviral Paxlovid, which has been added to the PANORAMIC national study
Stay updated with breaking news from Antivirals Taskforce. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Thousands more vulnerable people are eligible to receive the UK’s second antiviral Paxlovid, which has been added to the PANORAMIC national study
Thousands more vulnerable people in England are now eligible to receive the UK's second oral antiviral treatment for Covid.
New guidance outlines free COVID-19 tests will continue to be available to help protect specific groups once free testing for the general public ends on 1 April
People at risk of serious illness from COVID-19, and eligible for treatments, will continue to get free tests to use if they develop symptoms, along with NHS and adult social care staff and those in other high-risk settings, Health and Social Care Secretary Sajid Javid announced today (Tuesday 29 March).
As Covid treatments are changing, fewer patients are becoming seriously ill or dying.